Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.74 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.51 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2733942 | 0.98 | ALDH1A1 (0.71) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL5453594 | 0.98 | ALDH1A1 (0.71) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL4739976 | 0.94 | ALDH1A1 (0.77) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL1582969 | 0.90 | ALDH1A1 (0.91) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL5463183 | 0.88 | ALDH1A1 (0.87) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL8970703 | 0.88 | ALDH1A1 (0.87) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL8971430 | 0.88 | ALDH1A1 (0.87) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL8971393 | 0.88 | ALDH1A1 (0.87) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL8971703 | 0.88 | ALDH1A1 (0.87) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A | |
| SCHEMBL8971186 | 0.88 | ALDH1A1 (0.87) | ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9064633-B2 | Method for synthesizing quaternary ammonium systems | HONEYWELL INTERNATIONAL INC. (US) | 2015-06-23 | — | — | US | claimed |
| US-20130264510-A1 | METHOD FOR SYNTHESIZING QUATERNARY AMMONIUM SYSTEMS | HONEYWELL INT INC (US) | 2013-10-10 | — | — | US | claimed |
| US-8426593-B2 | Method for synthesizing quaternary ammonium systems | HONEYWELL INTERNATIONAL INC. (US) | 2013-04-23 | — | — | US | claimed |
| US-20070049750-A1 | Method for synthesizing spiro quartenary ammonium systems | HONEYWELL INTERNATIONAL INC. (US) | 2007-03-01 | — | — | US | claimed |
| EP-2139522-A2 | MITOCHONDRIA TARGETED CATIONIC ANTI-OXIDANT COMPOUNDS FOR PREVENTION, THERAPY OR TREATMENT OF HYPER-PROLIFERATIVE DISEASE, NEOPLASIAS AND CANCERS | Colby Pharmaceutical Company (US) | 2010-01-06 | — | — | EP | disclosed |
| WO-2008109740-A2 | MITOCHONDRIA TARGETED CATIONIC ANTI-OXIDANT COMPOUNDS FOR PREVENTION, THERAPY OR TREATMENT OF HYPER-PROLIFERATIVE DISEASE, NEOPLASIAS AND CANCERS | COLBY PHARMACEUTICAL COMPANY (US) | 2008-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070049750-A1 | Method for synthesizing spiro quartenary ammonium systems | REN, AGT, PKD1 | ALDH1A1 2665/4885CYP3A4 1863/4885CYP2C9 2809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.